Cryptococcosis Therapeutics Market Trends

• Cryptococcal infections have been on the rise globally, particularly affecting immunocompromised individuals such as those with HIV/AIDS, organ transplant recipients, and patients undergoing chemotherapy.
  
• For instance, as per the Global Action for Fungal Infections, globally, 179,000 cases of cryptococcal antigenaemia were estimated for 2020 with 152,000 cases of cryptococcal meningitis. Similarly, as per Clinicalinfo, cryptococcosis accounts for 15% of AIDS-related deaths globally.
  
• These infections can lead to severe neurological complications and even mortality if not promptly treated.
  
• The growing prevalence of these fungal infections underscores the urgent need for effective therapeutics, including antifungal agents and supportive care measures, driving the demand for innovative treatments, and boosting market growth in cryptococcosis therapeutics.